Great Point Partners as of March 31, 2025
Portfolio Holdings for Great Point Partners
Great Point Partners holds 32 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cytokinetics Com New (CYTK) | 7.9 | $15M | 370k | 40.19 | |
| Kalvista Pharmaceuticals (KALV) | 6.2 | $12M | 1.0M | 11.54 | |
| Evolus (EOLS) | 6.0 | $11M | 945k | 12.03 | |
| Abivax Sa Sponsored Ads (ABVX) | 5.4 | $10M | 1.6M | 6.25 | |
| Miragen Therapeutics (VRDN) | 5.4 | $10M | 750k | 13.48 | |
| Merus N V (MRUS) | 5.3 | $10M | 237k | 42.09 | |
| Akebia Therapeutics (AKBA) | 5.1 | $9.5M | 5.0M | 1.92 | |
| Xenon Pharmaceuticals (XENE) | 4.4 | $8.2M | 245k | 33.55 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 4.1 | $7.8M | 50k | 155.86 | |
| Dynavax Technologies Corp Com New (DVAX) | 4.1 | $7.7M | 596k | 12.97 | |
| Ionis Pharmaceuticals (IONS) | 4.0 | $7.5M | 250k | 30.17 | |
| Amylyx Pharmaceuticals (AMLX) | 3.4 | $6.4M | 1.8M | 3.54 | |
| Immunovant (IMVT) | 3.4 | $6.4M | 375k | 17.09 | |
| Unicycive Therapeutics | 3.3 | $6.3M | 11M | 0.57 | |
| Neurogene (NGNE) | 2.9 | $5.5M | 471k | 11.71 | |
| Dianthus Therapeutics (DNTH) | 2.6 | $5.0M | 275k | 18.14 | |
| Summit Therapeutics Put Option (SMMT) | 2.6 | $4.8M | 250k | 19.29 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 2.5 | $4.7M | 138k | 33.93 | |
| Vaxcyte (PCVX) | 2.3 | $4.4M | 116k | 37.76 | |
| Autolus Therapeutics Spon Ads (AUTL) | 2.2 | $4.2M | 2.7M | 1.55 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 2.2 | $4.2M | 374k | 11.30 | |
| Zura Bio Class A Ord Shs (ZURA) | 2.2 | $4.1M | 3.2M | 1.29 | |
| Beam Therapeutics (BEAM) | 1.8 | $3.4M | 176k | 19.53 | |
| Arcellx Common Stock (ACLX) | 1.6 | $3.0M | 45k | 65.60 | |
| Mereo Biopharma Group Spon Ads (MREO) | 1.5 | $2.9M | 1.3M | 2.25 | |
| Context Therapeutics (CNTX) | 1.5 | $2.9M | 4.7M | 0.61 | |
| Rezolute Com New (RZLT) | 1.3 | $2.4M | 833k | 2.90 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.1 | $2.2M | 150k | 14.38 | |
| Voyager Therapeutics (VYGR) | 1.1 | $2.1M | 626k | 3.38 | |
| Promis Neurosciences Com New (PMN) | 1.0 | $1.8M | 2.6M | 0.70 | |
| Upstream Bio (UPB) | 1.0 | $1.8M | 300k | 6.12 | |
| Pliant Therapeutics (PLRX) | 0.6 | $1.1M | 850k | 1.35 |
